In patients with localized cutaneous leishmaniasis a compromise is attained in which the parasite load is kept in check by an immune response whose magnitude is regulated by the action of regulatory cytokines such as IL-10 or TGF-β (Scott and Novais, 2016). This evidence concerns the gene TGFB1 and cutaneous leishmaniasis.